NanoMal is developing a 15 minute diagnostic and drug resistance test.
The NanoMal project integrates QuantuMDx’s pioneering handheld laboratory and sequencing technologies with malaria assay development by world-renowned anti-malarial drug resistance experts St George’s, University of London, the Karolinska Institutet, and Eberhard Karls Universität Tübingen.
The Future of malaria diagnosis
Our FP7 European Union-funded NanoMal Consortium is developing a handheld laboratory that will deliver complex malaria diagnostics in minutes for a few dollars in any setting across the globe.
Making malaria elimination possible
Our handheld laboratory will provide frontline health workers with the definitive tool to diagnose,
manage and monitor malaria and drug resistance.
- Results in 10-15 minutes
- Malaria diagnosis & drug resistance testing
- Directs right first time prescribing
- Handheld, user-friendly, low cost
- Mobile data connection